AI Revolutionizes Drug Discovery: Faster Molecular Simulations for Breakthrough Treatments
A new AI-driven molecular simulation engine, developed by researchers at MIT and Stanford, has cut drug discovery timelines by 40% by leveraging sparse tensor networks and hybrid quantum-classical optimization. The ... Read More